- Phare
- Validé par KD/KO
Anticorps Polyclonal de lapin anti-ISG15
ISG15 Polyclonal Antibody for WB, IHC, IF/ICC, IF-P, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, souris et plus (3)
Applications
WB, IHC, IF/ICC, IF-P, IP, CoIP, RIP, ELISA
Conjugaison
Non conjugué
N° de cat : 15981-1-AP
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en WB | cellules HeLa, cellules A549, cellules HepG2, cellules MCF-7, cellules PC-3, tissu cérébral humain |
Résultats positifs en IHC | tissu de cancer du poumon humain, tissu de cancer du pancréas humain il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0. |
Résultats positifs en IF-P | tissu cérébral de souris |
Résultats positifs en IF/ICC | cellules HeLa, |
Dilution recommandée
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:1000-1:4000 |
Immunohistochimie (IHC) | IHC : 1:50-1:500 |
Immunofluorescence (IF)-P | IF-P : 1:50-1:500 |
Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Informations sur le produit
15981-1-AP cible ISG15 dans les applications de WB, IHC, IF/ICC, IF-P, IP, CoIP, RIP, ELISA et montre une réactivité avec des échantillons Humain, souris
Réactivité | Humain, souris |
Réactivité citée | Chèvre, Humain, porc, singe, souris |
Hôte / Isotype | Lapin / IgG |
Clonalité | Polyclonal |
Type | Anticorps |
Immunogène | ISG15 Protéine recombinante Ag8782 |
Nom complet | ISG15 ubiquitin-like modifier |
Masse moléculaire calculée | 165 aa, 18 kDa |
Poids moléculaire observé | 15-17 kDa |
Numéro d’acquisition GenBank | BC009507 |
Symbole du gène | ISG15 |
Identification du gène (NCBI) | 9636 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Purification par affinité contre l'antigène |
Tampon de stockage | PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3 |
Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
ISG15 is a ubiquitin-like protein that becomes conjugated to many cellular proteins upon activation by interferon-alpha (IFNA) and -beta (IFNB). ISG15 forms covalent conjugates with its target proteins in a process called ISGylation, which in mammals is known to play a role in antiviral immunity. ISG15 proteins possess two ubiquitin-like (UBL) domains and a highly conserved C-terminal LRGG sequence, the latter being known as the ubiquitin conjugation motif. Intracellular ISG15 are conjugated, via the LRGG motif, to target proteins through a process called ISGylation, which resembles largely ubiquitination, the process of formation of ubiquitin conjugates. Unconjugated extracellular ISG15, which are released from several types of human and murine cells, are known to possess cytokine-like activity.
Protocole
Product Specific Protocols | |
---|---|
WB protocol for ISG15 antibody 15981-1-AP | Download protocol |
IHC protocol for ISG15 antibody 15981-1-AP | Download protocol |
IF protocol for ISG15 antibody 15981-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Signal Transduct Target Ther TRAF3 activates STING-mediated suppression of EV-A71 and target of viral evasion | ||
Exp Mol Med SIRT1 ISGylation accelerates tumor progression by unleashing SIRT1 from the inactive state to promote its deacetylase activity | ||
Nat Commun Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer's disease. | ||
Nat Commun ISGylation controls exosome secretion by promoting lysosomal degradation of MVB proteins. | ||
J Exp Clin Cancer Res ISG15 and ISGylation modulates cancer stem cell-like characteristics in promoting tumor growth of anaplastic thyroid carcinoma
| ||
Cancer Lett Induction of IFIT1/IFIT3 and inhibition of Bcl-2 orchestrate the treatment of myeloma and leukemia via pyroptosis |
Avis
The reviews below have been submitted by verified Proteintech customers who received an incentive forproviding their feedback.
FH Tinne (Verified Customer) (06-27-2023) | This antibody worked really well for detecting an up regulation of ISG15 in IF. Highly recommend!
|
FH Chaohui (Verified Customer) (10-19-2021) | The antibody shows a high quality of free ISG15 and conjugated ISG15 spots
|